NDC 65219-259-05 - Piperacillin and Tazobactam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 65219-259
Requested NDC: 65219-259-05
Package NDCs from labels: 65219-259-05, 65219-259-45, 65219-259-15, 65219-259-55
Manufacturer: Fresenius Kabi USA, LLC | Mitim S.r.I.
Effective date: 2026-09-02
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Piperacillin and Tazobactam - Fresenius Kabi USA, LLC \| Mitim S.r.I.	Fresenius Kabi USA, LLC \| Mitim S.r.I.	2026-09-02	HUMAN PRESCRIPTION DRUG LABEL
Piperacillin and Tazobactam - Fresenius Kabi USA, LLC \| Mitim S.r.I.	Fresenius Kabi USA, LLC \| Mitim S.r.I.	2021-05-19	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65219-259-05	Piperacillin and Tazobactam	20 mL in 1 VIAL, SINGLE-USE	INJECTION, POWDER, LYOPHILIZED,	20	4
65219-259-45	Piperacillin and Tazobactam	10 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	10	4
65219-259-15	Piperacillin and Tazobactam	20 mL in 1 VIAL, SINGLE-USE	INJECTION, POWDER, LYOPHILIZED,	20	1
65219-259-55	Piperacillin and Tazobactam	10 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	10	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65219-259	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4	Current NDC, Legacy NDC, 2 package rows	20250516_a798faf5-cd97-4e35-a700-94c372978c46.zip
65219-259	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ]	1	Current NDC, Legacy NDC, 2 package rows	20210524_b9bd733c-1176-42cb-b318-1223b7e48dcb.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65219-259-05	EA - Each	65219-259	37246466-bb4b-41f6-abae-934ab88234d2	1	2021-09-07
65219-259-15	EA - Each	65219-259	eef3f28e-e037-4d94-9e37-01849206d83c	1	2021-09-07
65219-259-45	EA - Each	65219-259	e7a9019c-2606-4b23-bb03-6915fad17a1e	1	2021-09-07
65219-259-55	EA - Each	65219-259	438b3b40-54f5-4b3f-9cef-b0b3fbefcf3d	1	2021-09-07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 39 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zosyn	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Baxter Healthcare Corporation	8db6bd91-2106-4bfd-8cc8-38aaf1e18d17	2026-05-15	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
ZERBAXA	CEFTOLOZANE AND TAZOBACTAM	Merck Sharp & Dohme LLC	70ac1d90-eff3-4f0b-9f46-5846c571b32f	2026-05-12	Warnings, Adverse reactions	Exact identifier unii: UXA545ABTT
Piperacillin and Tazobactam and Sodium Chloride	PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE	B. Braun Medical Inc.	a63ca653-27d4-45fe-a744-77e0efe45220	2026-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Civica, Inc.	19e89f8b-316b-4dd2-9724-bfe0faeba408	2025-12-12	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	WG Critical Care, LLC	2cd82553-79dc-45f0-9755-2c08df524ed5	2025-10-31	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
piperacillin and tazobactam	PIPERACILLIN AND TAZOBACTAM	Civica, Inc.	7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4	2025-09-08	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Avenacy, LLC	668a2730-e95a-4639-a506-ae95a6502ca1	2025-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Eugia US LLC	39e19789-de4b-4fd1-ab1c-92f59496f496	2025-08-19	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Eugia US LLC	a5d8625e-e630-4076-bc55-46ebe861c6a5	2025-08-08	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
piperacillin and tazobactam	PIPERACILLIN AND TAZOBACTAM	ONESOURCE SPECIALTY PHARMA LIMITED	28258745-12e4-4f0f-b318-4a1a1bebc928	2025-07-21	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Avenacy, LLC	9114cea1-3338-487e-87fa-cc3a409d501a	2025-07-07	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	BluePoint Laboratories	1aba753c-d0c2-4b35-917a-9143dd4be468	2025-06-20	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Apotex Corp.	2c8f06a2-49b2-4169-94ef-182d13d248bf	2025-05-21	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Fresenius Kabi USA, LLC	c5cddf50-e486-4ffb-9bc6-ed67ad6bc154	2025-04-14	Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Fresenius Kabi USA, LLC	a798faf5-cd97-4e35-a700-94c372978c46	2025-04-14	Warnings, Adverse reactions	Exact identifier application number: ANDA203719 ndc (package): 65219-434-20 ndc (package): 65219-259-05 ndc (package): 65219-436-02 ndc (package): 65219-259-45 ndc (package): 65219-434-02 ndc (package): 65219-436-20 ndc (product): 65219-259 ndc (product): 65219-436 ndc (product): 65219-434 ndc11 (package): 65219025905 rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 spl id: 76af03be-bc73-40f9-bde0-31fe9c359ca2 spl set id: a798faf5-cd97-4e35-a700-94c372978c46 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Fresenius Kabi USA, LLC	6a894b94-171f-4217-81a2-0e84796b0b41	2025-04-11	Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Fresenius Kabi USA, LLC	c8e3cc43-238d-4a23-95dc-157c85f83184	2025-04-10	Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Provepharm Inc.	68d5384d-1691-4afc-8a1a-488f8e2ef2c5	2025-02-26	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
PIPERACILLIN AND TAZOBACTAM	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Provepharm Inc.	bc26ffd8-1a6e-4e16-91c1-ec67c928b3bf	2025-02-26	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Sandoz Inc	9b682c66-61c6-4ade-baf4-9d68911a16b8	2024-10-30	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.